About Dracen Pharmaceuticals
Dracen Pharmaceuticals is a private company based in San Diego, California. It has reported $19,358,294 raised in three offerings on Form D since January 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 11, 2023 | Aug 10, 2023 | $2,285,000of $2.7M target | 6 | $380K | DebtRule 506(b) | Form D ↗ |
| Nov 1, 2021 | Nov 10, 2021 | $8,584,398of $17.0M target | 8 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Jan 11, 2018 | Jan 24, 2018 | $8,488,896of $40.4M target | 9 | $943K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $19,358,294 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Dracen Pharmaceuticals's Form D filed Aug 10, 2023.
AR
Asher Rubin
Executive officer
DD
Drew Pardoll, M.D., Ph.D.
Director
DB
Dennis Bilski
Acting Chief Financial Officer
JL
Jonathan Leff
Director
Earlier filings also listed Thomas Estok (executive officer and director, last listed Nov 2021) and Robert Jackson (director, last listed Jan 2018).